期刊文献+

多效生长因子对基质金属蛋白酶3,10的负调控作用 被引量:1

Pleiotrophin Negative Regulate the Matrix Metalloproteinase 3 and 10
下载PDF
导出
摘要 目的:研究多效生长因子对基质金属蛋白酶(MMP)3、10的负调控作用。方法:用RT-PCR、Northern印迹比较对照与多效生长因子沉默细胞中MMP3、MMP10的表达;在多效生长因子沉默细胞培养液中加入50 ng/mL多效生长因子,检测MMP3、MMP10的表达。结果:多效生长因子缺失细胞中MMP3、MMP10高表达;而在其中添加多效生长因子之后,MMP3、MMP10的表达基本被完全抑制。结论:多效生长因子对MMP3、MMP10有负调控作用。 Objective: To investigate the transcription regulation of matrix metalloproteinase(MMP) 3, 10 by pleiotrophin (PTN). Methods: The mRNA expression levels of MMP3, MMP10 were compared between control and PTN knocking down MEF cells by RT-PCR and Northern Blot. Then, 50 ng/mL PTN was added in culture medium of the PTN knocking down MEF cells to investigate the effect of pleiotrophin on the transcription of MMP3, MMP10. Results: MMP3, MMP10 expressed higher in the cell that PTN was absence, but they expressed lower after the PTN effeeted. Conclusion: PTN negative regulated the expression of MMP3 and MMP10.
出处 《生物技术通讯》 CAS 2008年第1期28-30,共3页 Letters in Biotechnology
基金 国家自然科学基金项目(30471946) 北京市自然科学基金项目(7052056和5062036)
关键词 多效生长因子 基质金属蛋白酶 负调控 pleiotrophin matrix metalloproteinase negative regulation
  • 相关文献

参考文献15

  • 1Deuel T F, Zhang N, Yeh H J, et al. Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway [J]. Arch Biochem Biophys, 2002,397(2):162-171.
  • 2金霞,张健慧.基质金属蛋白酶基因多态性的研究进展[J].国外医学(遗传学分册),2005,28(2):76-79. 被引量:16
  • 3Li G, Robinson G W, Lesche R, et ol. Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland[J]. Development, 2002,129(17):4159-4970.
  • 4Li G, Hu Y, Huo Y, et al. PTEN deletion leads to up-regulation of a secreted growth factor pleiotrophin[J]. J Biol Chem, 2006,281(16):10663-10668.
  • 5胡迎春,刘敏丽,李刚,霍艳英,吴德昌.siRNA沉默多效生长因子表达及其生物学意义[J].癌症,2006,25(10):1210-1215. 被引量:5
  • 6Gerger A, Langsenlehner U, IRenner W, et al. A multigenic approach to predict breast cancer risk [J]. Breast Cancer IRes Treat, 2007,104(2): 159-164.
  • 7Hou Y Z, Okamoto C, Okada K, et al. C-Myc is essential for urokinase plasminogen activator expression on hypoxiainduced.vascular smooth muscle cells[J]. Cardiovascular Research, 2007,3:1-30.
  • 8Ito A, Nakajima S, Sasaguri Y, et al. Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1,2 and 3 in fibroblasts[J]. Br J Cancer, 1995,71(5):1039-1045.
  • 9Krejci P, Masri B, Fontaine V,et ol. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis[J]. J Cell Sci, 2005,118(Pt 21):5089-5100.
  • 10Wu B, Crampton S P, Hughes C C. Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration [J]. Immunity, 2007,26(2):227-239.

二级参考文献67

  • 1Ohashi K, Nemoto T, Nakamura K, et aL Increased expression of matrix metalloproteinase7 and 9 and membrane typel-matrix metalloproteinase in esophageal squamous cell carcinomas. Cancer,2000,88(10):2201-2209.
  • 2Morgan AR,Zhang B,Tapper W,et al. Haplotypic analysis of the MMP9 gene in relation to coronary artery disease. J Mol Med,2003,81(5):321-326.
  • 3Joos L, He JQ,Megan B,et al. The role of matrix metaloproteinase polymorphisrns in the rate of decline in lung function. Hum Mol Genet,2002,11(5):569-576.
  • 4Kerkela E,Ala-Aho R, Jeskanen L,et al. Expression of human macrophage metalloelastase (MMP12) by tumor colls in skin cancer. J Invest Dermatol,2000,114(6):1113-1119.
  • 5Ding Y, Shimada Y, Gorrin-Rivas MJ, et al. Clinicopathological significanco of human macrophage metalloelsstase expression in esophageal squamous cell carcinoma. Oncology,2002,63 (4):378-384.
  • 6Szyllo K,Smolarz B,Romanowicz-Makowska H,et al. The promoter polymorphism of the matrix metalloproteinase3 (MMP3)gene in women with ovarian cancer. Exp Clin Cancer Res, 2002,21 (3):357-361.
  • 7Liu PY,Chen JH,Li YH,et al. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction. Thromb Haemost,2003,90(1):132-139.
  • 8Ghilardi G,Biondi ML, Demonti M,et al. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke,2002,33 (10):2408-2412.
  • 9Satsangi J,Chapman RW,Haldar N,et al. A functional polymorphism of the stromelysin gene (MMP3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology, 2001,121(1):124-130.
  • 10Knox JD,Boreham DR,Walker JA,et al .Mapping of the metalloproteinase gene matrilysin(MMP7)to human chromosome11q21-q22. Cytogen Cell Genet, 1996, 72(2-3):179-182.

共引文献18

同被引文献35

  • 1程虹,戴林,郭双平.乳腺及女性生殖器官肿瘤病理学和遗传学[M].北京:人民卫生出版社,2006.1-124.
  • 2Relf M, LeJeune S, Scott PA, et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor b-1, plateletderived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis[J]. Cancer Res, 1997, 57(5): 963-969.
  • 3Fang W, Hartmann N, Chow DT, et al. Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer[J]. J Biol Chem, 1992, 267(36): 25889-25897.
  • 4Kadomatsu K, Muramatsu T. Midkine and pleiotrophin in neural development and cancer[J]. Cancer Lett, 2004, 204(2): 127- 143.
  • 5Zhang N, Zhong R, Wang ZY, et al, Human breast cancer growth inhibited in vivo by a dominant negative pleiotrophin mutant[J]. J Biol Chem, 1997, 272(27): 16733 - 16736.
  • 6Shimizu M, Saitoh Y, Itoh H, et al. Immunohistochemical staining of Ha-ras ongene product in normal, benign, and malignant human pancreatic tissue[J]. Hum Pathol, 1990, 21 (6): 607-612.
  • 7Gluz O, Liedtke C, Gottschalk N, et al. Triple-negative breast cancerdcurrent status and future directions[J]. Ann Oncol, 2009, 20(12): 1913-1927.
  • 8Rakha EA, E1-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer[J]. Cancer, 2007, 109(1): 25-32.
  • 9Cheang MC, Voduc D, Bajdik C, et al. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype[J]. Clin Cancer Res, 2008, 14(5): 1368-1376.
  • 10Perou CM, Sorlie T, Eisen M B, et al. Molecular portrait of human breast tumors[J]. Nature, 2000, 406(6797): 747-752.

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部